PL398411A1 - Zastosowanie kwasu naftylo-1,5-diaminobis(metylidenobisfosfonowego) w preparacie farmaceutycznym - Google Patents

Zastosowanie kwasu naftylo-1,5-diaminobis(metylidenobisfosfonowego) w preparacie farmaceutycznym

Info

Publication number
PL398411A1
PL398411A1 PL398411A PL39841112A PL398411A1 PL 398411 A1 PL398411 A1 PL 398411A1 PL 398411 A PL398411 A PL 398411A PL 39841112 A PL39841112 A PL 39841112A PL 398411 A1 PL398411 A1 PL 398411A1
Authority
PL
Poland
Prior art keywords
methylidenobisphosphonic
diaminobis
naphthyl
acid
pharmaceutical preparation
Prior art date
Application number
PL398411A
Other languages
English (en)
Other versions
PL217017B1 (pl
Inventor
Waldemar Goldeman
Anna Nasulewicz-Goldeman
Original Assignee
Politechnika Wrocławska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Wrocławska filed Critical Politechnika Wrocławska
Priority to PL398411A priority Critical patent/PL217017B1/pl
Publication of PL398411A1 publication Critical patent/PL398411A1/pl
Publication of PL217017B1 publication Critical patent/PL217017B1/pl

Links

PL398411A 2012-03-12 2012-03-12 Zastosowanie kwasu naftylo-1,5-diaminobis(metylidenobisfosfonowego) w preparacie farmaceutycznym PL217017B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL398411A PL217017B1 (pl) 2012-03-12 2012-03-12 Zastosowanie kwasu naftylo-1,5-diaminobis(metylidenobisfosfonowego) w preparacie farmaceutycznym

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL398411A PL217017B1 (pl) 2012-03-12 2012-03-12 Zastosowanie kwasu naftylo-1,5-diaminobis(metylidenobisfosfonowego) w preparacie farmaceutycznym

Publications (2)

Publication Number Publication Date
PL398411A1 true PL398411A1 (pl) 2012-07-16
PL217017B1 PL217017B1 (pl) 2014-06-30

Family

ID=46575897

Family Applications (1)

Application Number Title Priority Date Filing Date
PL398411A PL217017B1 (pl) 2012-03-12 2012-03-12 Zastosowanie kwasu naftylo-1,5-diaminobis(metylidenobisfosfonowego) w preparacie farmaceutycznym

Country Status (1)

Country Link
PL (1) PL217017B1 (pl)

Also Published As

Publication number Publication date
PL217017B1 (pl) 2014-06-30

Similar Documents

Publication Publication Date Title
SI3336097T1 (sl) Priprava nekristalinične oblike obetiholne kisline
HK1203812A1 (en) Novel pharmaceutical formulations
SG10201604667YA (en) Pharmaceutical preparation
HK1225714A1 (zh) 3-雜芳酰基氨基-丙酸衍生物及其作為藥物的用途
HK1205146A1 (en) Pharmaceutical formulation
AP3803A (en) Pharmaceutical dosage form
AP2015008208A0 (en) Pharmaceutical administration forms comprising
PL2854765T3 (pl) Farmaceutyczny roztwór pemetreksedu
GB201105298D0 (en) Pharmaceutical preparation
HK1211570A1 (en) Indene derivatives, their preparation and use as medicaments
HK1205683A1 (en) Pharmaceutical formulation having improved stability
LT3473255T (lt) Farmacinė vaisto forma, apimanti ciklezonidą
PL2691119T3 (pl) Preparat farmaceutyczny
HK1204613A1 (en) Substituted pyrano and furanoquinolines, their preparation and use as medicaments
HK1209339A1 (en) Pharmaceutical formulations
PL398414A1 (pl) Zastosowanie kwas fenylo-1,4-diaminobis(metylidenobisfosfonowego) w preparacie farmaceutycznym
PL398411A1 (pl) Zastosowanie kwasu naftylo-1,5-diaminobis(metylidenobisfosfonowego) w preparacie farmaceutycznym
SG11201504068UA (en) Orally administered liquid formulation
PL398410A1 (pl) Zastosowanie kwasu naftylo -1,5-diaminobis(metylidenobisfosfonowego) do wytwarzania preparatu farmaceutycznego
ZA201502354B (en) Pharmaceutical dosage form
HK1198931A1 (en) Process for obtaining a modafinil-based pharmaceutical composition, resulting pharmaceutical composition and use thereof
PL399720A1 (pl) Zastosowanie kwasów bifenylo-4,4'-diaminobis(metylidenobisfosfonowych) do wytwarzania preparatu farmaceutycznego
PL398409A1 (pl) Zastosowanie kwasów bifenylo-4,4'-diaminobis(metylidenobisfosfonowych) do wytwarzania preparatu farmaceutycznego
GB201211406D0 (en) Pharmaceutical formulations
GB201211403D0 (en) Pharmaceutical formulations